Browsing: public

Sports betting is thriving across the world, but consistently making money is far from simple. Bettors have an opportunity to compare today’s best odds at https://1xbet.ie. One of the best long-term plans is opposite betting-a way that means going against what most people think to get better odds and lasting worth. What Are Public Betting Trends? Public betting trends (also known as betting splits) reveal how the general betting public is wagering on a particular event. These trends show: For instance, if 80% of wagers are on Team A to win and 20% on Team B, Team A is the…

Mercell, a leading provider of public tendering and bidding technology, has launched its next-generation Mercell Tendering platform, set to transform procurement practices for public buyers across Europe. The new platform is designed to simplify and automate the tendering process, offering a more intuitive and efficient solution for both small and large public sector organisations. The Mercell Tendering platform introduces a range of innovative features aimed at enhancing the procurement landscape. These include automated workflows, seamless integration with existing systems, access to a vast network of suppliers, and full compliance with European and national regulations. The platform’s user-friendly interface ensures that…

The number of people receiving charitable support has tripled in four years as cost-of-living pressures intensify. The Charity Commission, the regulator of charities in England and Wales, has released new research indicating that public trust in charities has reached its highest level since 2014. The research highlights that the most important factor for most people is understanding how a charity spends its money. This is closely followed by the knowledge that the charity achieves its purpose, makes a difference, and operates to high ethical standards. Overall, trust in charities remains strong and continues to recover. Charities now score 6.5 out…

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing innovative product candidates to treat brain health disorders, today announced the pricing of an underwritten public offering of 9,285,511 common shares, without par value, at a public offering price of $7.00 per common share. Additionally, to certain investors, the Company is offering pre-funded warrants to purchase 1,428,775 common shares at a price of $6.999 per pre-funded warrant, which represents the per-share public offering price for the common shares, less the $0.001 per share exercise price for each pre-funded warrant. The gross proceeds to MindMed from…